3,843 Followers on Owler
OverviewCompetitorsAcquisitionsFundingInvestmentsNews & Insights

Alexion Competitors or Alternatives

Alexion's top competitors include NexImmune, Coherus and Regeneron.

Unlock 26 more competitors →

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

  • FUNDING

    REVENUE

  • EMPLOYEES

    FUNDING

  • REVENUE

  • CEO RATING

  • EMPLOYEES

  • FUNDING

  • REVENUE

Alexion's company profile

Marc Dunoyer

CEO

- -
1,000 - 5,000
$18M
$5B - 10B
  • $18M
    $5B - 10B
  • 1,000 - 5,000
    $18M
  • $5B - 10B
  • - -
  • 1,000 - 5,000
  • $18M
  • $5B - 10B
View ProfileView
1
Alexion's Competitor - NexImmune logo

Kristi Jones

CEO

86/100
6
$166.4M
  • $166.4M
  • 6
    $166.4M
  • 86/100
  • 6
  • $166.4M
View ProfileView
2
Alexion's Competitor - Coherus logo

Dennis M. Lanfear

Chairman & CEO

40/100
330
$544.8M
$267M
  • $544.8M
    $267M
  • 330
    $544.8M
  • $267M
  • 40/100
  • 330
  • $544.8M
  • $267M
View ProfileView
3
Alexion's Competitor - Regeneron logo

Leonard S. Schleifer

President & CEO

73/100
11,900
$2.1B
$14.1B
  • $2.1B
    $14.1B
  • 11,900
    $2.1B
  • $14.1B
  • 73/100
  • 11,900
  • $2.1B
  • $14.1B
View ProfileView
4
Alexion's Competitor - Chugai Pharmaceutical logo

Tatsuro Kosaka

Chairman & CEO

90/100
7,604
- -
$6.8B
  • - -
    $6.8B
  • 7,604
    - -
  • $6.8B
  • 90/100
  • 7,604
  • - -
  • $6.8B
View ProfileView
5
Alexion's Competitor - Amgen logo

Robert A. Bradway

Chairman & CEO

51/100
25,200
$4.1B
$33.4B
  • $4.1B
    $33.4B
  • 25,200
    $4.1B
  • $33.4B
  • 51/100
  • 25,200
  • $4.1B
  • $33.4B
View ProfileView
Alexion's top 29 competitors are NexImmune, Coherus, Regeneron, Apellis, Chugai Pharmaceutical , Amgen, Genentech, Shire, Novartis, Amyndas Pharmaceuticals, Akari Therapeutics, MannKind, Gilead, Kite Pharma, Johnson & Johnson, AbbVie, Biogen, Boehringer Ingelheim, Icagen, AstraZeneca, Roche, BioAtla, Ferring Pharmaceuticals, One Drop, Prometheus Laboratories, Warner Chilcott, Pharming, Nypro and Merz. Together they have raised over 33.2B between their estimated 664.2K employees. Alexion's revenue is the ranked 14th among it's top 10 competitors. The top 10 competitors average 17.3B. Alexion has 3,000 employees and is ranked 16th among it's top 10 competitors. The top 10 competitors average 23,007.

Alexion VS NexImmune

NexImmune is one of Alexion's top competitors. NexImmune is a Public company that was founded in Gaithersburg, Maryland in 2011. NexImmune is in the Biotechnology field. NexImmune has 2,994 fewer employees vs. Alexion.

Alexion VS Coherus

Coherus is perceived as one of Alexion's biggest rivals. Coherus was founded in 2010 in Redwood City, California. Coherus competes in the Biotechnology industry. Coherus generates $6B less revenue than Alexion.

Alexion VS Regeneron

Regeneron is a top competitor of Alexion. Regeneron's headquarters is in Tarrytown, New York, and was founded in 1988. Regeneron competes in the Biotechnology field. Regeneron generates 223% of Alexion's revenue.

Looking for similar companies to Alexion?

Similar Companies

Companies in Boston with revenue in $5.0-10B range

See 10 companies 
Companies in Boston with employees in 1.0-5.0K range

See 92 companies 
Companies in Greater Boston with revenue in $5.0-10B range

See 18 companies 
Companies in Massachusetts with revenue in $5.0-10B range

See 21 companies 
Pharmaceuticals & Biotechnology companies with revenue in $5.0-10B range

See 29 companies 
Pharmaceuticals companies in Boston

See 89 companies 
Pharmaceuticals companies with revenue in $5.0-10B range

See 18 companies 
Pharmaceuticals companies with employees in 1.0-5.0K range

See 202 companies 
Pharmaceuticals & Biotechnology companies in Boston

See 339 companies 

Advanced Search

PRO

Discover new companies using five search parameters, including sector, location, public/private company status, employee count, and annual revenue.

Discover new companies using five search parameters.

Trending News for Alexion and Alexion's Competitors

April 29, 2025Yahoo
In This Article: Regeneron Pharmaceuticals, Inc. REGN reported first-quarter 2025 adjusted earnings per share (EPS) of $8.22, which missed the Zacks Co...
April 30, 2025Endpoints News
Novartis plans to acquire Regulus Therapeutics for $7.00 per share in cash, or $800 million, the microRNA specialist said Wednesday. This is more than ...
April 30, 2025GlobalNewswire
WALTHAM, Mass., April 30, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company will host a conference...
April 30, 2025FinanzNachrichten
NEW BRUNSWICK (dpa-AFX) - Johnson & Johnson (JNJ) announced the FDA has approved IMAAVY, a human FcRn-blocking monoclonal antibody, for the treatment o...
April 30, 2025Pharmabiz
AbbVie announced the US Food and Drug Administration (FDA) has approved Rinvoq (upadacitinib), 15 mg, once daily, for the treatment of adults with gian...
April 29, 2025Marketscreener
CAMBRIDGE , Britain (AP) - CAMBRIDGE , Britain (AP) - Astrazeneca PLC (AZN) on Tuesday reported first-quarter profit of $2.92 billion . On a per-share ...
April 30, 2025Pharmabiz
Boehringer Ingelheim reported new and updated data from the Beamion LUNG─1 trial evaluating zongertinib in previously treated patients with HER2 (ERBB2...
April 29, 2025FinanzNachrichten
NORTHAMPTON, MA / ACCESS Newswire / April 29, 2025 / Gilead is committed to using its virology expertise to advance HIV treatment and prevention to hel...
April 29, 2025Zacks
Volume growth of AMGN's key drugs like Evenity, Repatha and Kyprolis is expected to have been partially offset by biosimilar/generic competition for ma...
April 29, 2025PMLiVE
More than 35,000 new cases of the blood cancer are diagnosed in Europe every year...

Frequently Asked Questions about Alexion

  1. Who are Alexion's top competitors?

    Alexion's top 3 competitors are NexImmune, Coherus, Regeneron.

  2. Who is similar to Alexion?

    NexImmune is the most similar to Alexion. Coherus and Regeneron are also similar to Alexion.

  1. Are Alexion and NexImmune competitors?

    Yes, NexImmune is one of Alexion’s top competitors.